메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

'김갑성' 기자의 전체기사

Ductal Carcinoma In Situ Discovery from Gynecomastia Surgery…

[ 메디채널 김갑성 기자 ] Gynecomastia can indicate underlying health concerns, including cancer, and surgery provides an opportunity to examine tissues for abnormalities. Early detection saves lives. SINGAPORE, Aug. 6, 2025 -- Dr Ivan Puah, an MOH-accredited liposuction doctor at Amaris B. Clinic, with decades of experience in male chest contouring and gynecomastia surgery, emphasises the critical significance of adhering to rigorous surgical protocols and conducting comprehensive diagnostics. This includes the essential practice of sending every case of gynecomastia surgery for thorough hist
- 김갑성 기자
- 2025-08-06 16:38
Thyseed Newborn Baby Bottle with Bottom Vent Design: Clinic…

[ 메디채널 김갑성 기자 ] New anti-colic system delivers clinically tested relief for newborn digestive discomfort BEIJING, Aug. 6, 2025 -- Thyseed, an established name in global infant care, has announced the launch of its newborn baby bottle featuring proprietary bottom vent technology for global markets. Clinical trials confirm that this design reduces colic and spit-up by more than 30% among infants aged 0-3 months. The product is fully certified by the US FDA and relevant EU authorities, with all components passing more than 40 safety and performance tests by Swiss testing agency SGS. It
- 김갑성 기자
- 2025-08-06 14:38
Thyseed Is Set to Support Southeast Asian Families with Safe…

BEIJING, Aug. 6, 2025 -- Thyseed, an established name in global infant care, recently announced plans to introduce its premium, safety-certified feeding solutions to Southeast Asian households in 2025. With an established presence in the United States, Russia, and mainland China, Thyseed is committed to extending its industry-leading safety standards to new markets. Since its inception, Thyseed has championed a commitment to safeguarding infants from their earliest interactions with feeding products in a move to transform infant feeding safety through profound consumer insights and gro
- 김갑성 기자
- 2025-08-06 13:52
Everest Medicines Announces Full Approval of NEFECON® in T…

SHANGHAI, Aug. 6, 2025 -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced the Taiwan Food and Drug Administration (TFDA) has approved the supplementary application for NEFECON®. NEFECON® is indicated to reduce the loss of kidney function in adults with primary immunoglobulin A nephropathy (IgAN) who are at risk for disease progression, irrespective of proteinuria levels. With this label u
- 김갑성 기자
- 2025-08-06 13:09
4 in 5 APAC consumers take health supplements but half lac…

Preventive health trend driving need for credible and trusted sources of information HONG KONG, Aug. 6, 2025 -- Herbalife, a premier health and wellness company and community, today released findings from its 2025 Asia Pacific Responsible Supplementation Survey, revealing that while there is widespread use of health supplements in Asia Pacific (APAC), many lack the confidence to make good supplement decisions. Four in five (80%) consumers in the region take health supplements regularly, but only half (50%) expressed confidence in their ability to make responsible supplement cho
- 김갑성 기자
- 2025-08-06 11:00
アジア・パシフィック地域の消費者の5人中4人が健康サプリメントを摂取、一方で半数が…

予防的な健康志向の高まりが、信頼できる情報源の必要性を後押し香港、2025年8月6日 -- 健康とウェルネスのリーディング・カンパニーでありコミュニティでもあるHerbalifeは本日、2025 Asia Pacific Responsible Supplementation Surveyの結果を発表し、アジア・パシフィック地域（APAC）では健康サプリメントが広く使用されている一方で、適切なサプリメントの摂取を決定できる自信がない人が多いことが明らかになりました。この地域の消費者の5人のうち4人（80%）は健康サプリメントを定期的に摂取していますが、責任あるサプリメントを確信を持って選択できていると答えたのは半数（50%）にとどまりました。 2025年5月に実施されたこの調査では、アジア・パシフィック地域の健康サプリメントに対する消費者の態度と行動を調査しました。調査では、「責任あるサプリメントの選択」とは、「健康サプリメント製品を摂取する前に、その製品の成分組成、品質、推奨摂取量、摂取制限、他のサプリメントや医薬品との相互作用の可能性について十分に理解する行為」と定義されています。回答者はオーストラリア、香港、インドネシア、日本、韓国、マレーシア、フィリピン、シンガポール、台湾、タイ、ベトナムの11の市場にまたがる
- 김갑성 기자
- 2025-08-06 11:00
From AI to Precision Medicine: Taiwan's Smart Healthcare Inn…

DALLAS, Aug. 6, 2025 -- The Smart Healthcare Pavilion at Taiwan Expo USA 2025 will take place at the Kay Bailey Hutchison Convention Center in Dallas, Texas, from August 14 to 16. Featuring two world-leading hospitals and eight cutting-edge companies, the pavilion highlights Taiwan's exceptional strengths in telemedicine, AI-driven solutions, and precision medicine. Smart Hospitals Leading Global Innovation Two hospitals named among Newsweek's World's Best Smart Hospitals 2025 will unveil groundbreaking healthcare innovations: Taichung Veterans General Hospital
- 김갑성 기자
- 2025-08-06 10:43
Bracco Imaging Receives Regulatory Approval in China for So…

New indication of SonoVue® supports non-invasive assessment of female infertility through contrast-enhanced ultrasound in China MILAN, Aug. 6, 2025 -- Bracco Imaging, a global leader in diagnostic imaging, today announced that its ultrasound contrast agent SonoVue® has been approved by the China's National Medical Products Administration (NMPA) for use in hysterosalpingo contrast sonography (HyCoSy). HyCoSy is a contrast-enhanced ultrasound (CEUS) procedure that helps identifying potential causes of female infertility related to blockage of the fallopian tubes or
- 김갑성 기자
- 2025-08-06 08:00
U.S., Japan, and Taiwan Experts Gather at NUWA Forum -- Over 20…

[ 메디채널 김갑성 기자 ] Is Increased Use of PGT-A Always Better? Experts Call for Evidence-Based Use of Mosaic EmbryosChoosing the Right PGT-A Platform: NUWA Fertility and Global Experts Unite to Advance IVF Success TAIPEI, Aug. 6, 2025 -- Preimplantation Genetic Testing for Aneuploidy (PGT-A), a screening method used during IVF to assess embryo chromosomal health, has gained widespread adoption in reproductive medicine worldwide. Yet the accuracy of various PGT-A platforms and their true clinical value remain points of ongoing debate. To dive deeper into the science behind PGT-A and explore
- 김갑성 기자
- 2025-08-06 08:00
WuXi AppTec Named Constituent of the FTSE4Good Index Seri…

SHANGHAI, Aug. 6, 2025 -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, today announced its inclusion in the FTSE4Good Index Series for the third consecutive year. This recognition underscores the Company's ongoing commitment to sustainable development and its efforts to build a healthier, more sustainable world. Created by the global index and data provider FTSE Russell, the FTSE4Good Index Series is designed to measure the performance of companies demonstrating
- 김갑성 기자
- 2025-08-06 08:00

이전

11 12 13 14 15 16 17 18 19 20

많이 본 기사

최근기사

2025-08-20_WED

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 08월 21일 01시 40분